Dare Bioscience files resale registration for shares tied to August warrants
The S-1 covers up to 8,934,345 shares issuable from warrants tied to Dare's August 14 private placement and registered direct offering.
SEC filing (4)
Latest
2 stories
Wednesday, August 26
Thursday, August 13
Dare Bioscience reports Q2 2026 results as first direct product launches
The company began selling Flora Sync LF5 in July and reported positive interim Phase 3 data for Ovaprene while starting a Phase 2 study of DARE-HPV.
SEC filing